259 related articles for article (PubMed ID: 35940204)
1. Hormone- and antibody-mediated activation of the thyrotropin receptor.
Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody mimicry of hormone action at the thyrotropin receptor.
Faust B; Billesbølle CB; Suomivuori CM; Singh I; Zhang K; Hoppe N; Pinto AFM; Diedrich JK; Muftuoglu Y; Szkudlinski MW; Saghatelian A; Dror RO; Cheng Y; Manglik A
Nature; 2022 Sep; 609(7928):846-853. PubMed ID: 35940205
[TBL] [Abstract][Full Text] [Related]
3. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
Hamidi S; Chen CR; McLachlan SM; Rapoport B
Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
[TBL] [Abstract][Full Text] [Related]
4. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
5. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
6. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
7. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
[No Abstract] [Full Text] [Related]
8. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.
Núñez Miguel R; Sanders J; Sanders P; Young S; Clark J; Kabelis K; Wilmot J; Evans M; Roberts E; Hu X; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2012 Oct; 49(2):137-51. PubMed ID: 22829655
[TBL] [Abstract][Full Text] [Related]
10. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Action of TSHR Autoantibodies.
Furmaniak J; Sanders J; Núñez Miguel R; Rees Smith B
Horm Metab Res; 2015 Sep; 47(10):735-52. PubMed ID: 26361260
[TBL] [Abstract][Full Text] [Related]
12. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.
Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A
Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
14. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
15. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
16. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
17. Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms.
Hamidi S; Chen CR; Murali R; McLachlan SM; Rapoport B
Endocrinology; 2013 Jan; 154(1):562-71. PubMed ID: 23183178
[TBL] [Abstract][Full Text] [Related]
18. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis.
Chen CR; Hubbard PA; Salazar LM; McLachlan SM; Murali R; Rapoport B
Mol Endocrinol; 2015 Jan; 29(1):99-107. PubMed ID: 25419797
[TBL] [Abstract][Full Text] [Related]
20. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
